To describe a new beam arrangement for preoperative concurrent boost radiotherapy in locally advanced rectal carcinoma.
Material and methods
Three different volumes, ie posterior pelvis, total mesorectal space, and gross tumor volume plus 2 cm, are selected to receive radiation doses of 47 Gy, 51 Gy, and 54 Gy, respectively, in 24 fractions. There are two prerequisites for the use of such a radiotherapy schedule: complete displacement of the small bowel outside the boost volume, and horizontal positioning of the rectal long axis. Both conditions can be attained by patient positioning on a new device, the “Up-Down Table” (UDT). The dose gradient between the three volumes is realized with two daily arc rotation fields with an isocenter that is different from the three additional multileaf collimator pelvic fields (postero-anterior + 2 laterolateral).
Results
The treatment data are reported according to the ICRU 62 criteria. A comparison was made between concurrent arc rotation and concomitant static boost techniques.
Conclusion
The new beam arrangement, with the use of the UDT, allows to administer different radiation doses to three volumes with different tumor cell density in order to obtain the same probability of local response in all target volumes without increasing the toxicity.
BergerC., De MuretA., GaraudP., ChapetS., BuorlierP., Reynaud-BougnouxA., DorvalE., De CalanL., HuntenN., Le FlochO., CalaisG.: Preoperative radiotherapy (RT) for rectal cancer: predictive factors of tumor downstaging and residual tumor cell density (RTCD): prognostic implications. Int J Radiat Oncol Biol Phys37: 619–627, 1997.
5.
JanjanN.A., KhooV.S., AbruzzeseJ.: Tumour downstaging and sphincter preservation with pre-operative chemoradiation in locally advanced rectal cancer: the MD Anderson Cancer Center Experience. Int J Radiat Oncol Biol Phys, 44: 1027–1038, 1999.
6.
WilletC.G.: The role of radiation therapy and 5-fluorouracil in colon and rectal cancer. Semin Radiat Oncol, 7: 300–305, 1997.
7.
GrannA., MinskyB.D., CohenA.M.: Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer. Dis Colon Rectum, 40: 515–522, 1999.
8.
MinskyB.D., CohenA.M., EnkerW.E.: Preoperative 5-FU low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancer. Int J Radiat Oncol Biol Phys, 37: 289–295, 1997.
9.
AckerJ.C., MarksL.B.: The lack of impact of pelvic irradiation on small bowel mobility: implications for radiotherapy treatment planning. Int J Radiat Oncol Biol Phys, 32: 1473–1475, 1995.
10.
DasI.J., LancianoR.M., MovsasB., KagawaK., BarnesS.J.: Efficacy of a belly board device with CT-simulation in reducing small bowel volume within pelvic irradiation fields. Int J Radiat Oncol Biol Phys, 39: 67–76, 1997.
11.
LetschertJ.G.J., LebesqueJ.V., AlemanB.M.B.: The volume effect in radiation-related late small bowel complications: results of a clinical study of the EORTC Radiotherapy Cooperative Group in patients treated for rectal carcinoma. Radiother Oncol, 32: 116–123, 1994.
12.
MinskyB.D., ContiJ.A., HuangY., KnopfK.: The relationship of acute gastrointestinal toxicity and the volume of irradiated small bowel in patients receiving combined modality therapy for rectal cancer. J Clin Oncol, 13: 1409–1416, 1995.
13.
CapirciC., StevaninC., MandolitiG., LavederF., PolicoC.: Small bowel exclusion during pelvic RT by “dynamic” planning at universal simulator: advantages vs “static” CT-plan. Radiother Oncol, 32 (Suppl): 627, 1994.
14.
CapirciC., PolicoC., ValentiniV., MandolitiG., PavanatoG., RosettiM.E., MorgantiA.G.: Optimization of pelvic radiotherapy and related topics: an interactive course on CD-rom. Radiother Oncol, 48: 828, 1998.
15.
GlimeliusB., IsacssonU., JungB., PahlmanL.: Radiotherapy in addition to radical surgery in rectal cancer: evidence for a dose-response effect favouring preoperative treatment. Int J Radiat Oncol Biol Phys, 37: 281–287, 1997.
WongR., ThomasG., CummingsB., FraudP., ShelleyW., WithersR., WilliamsJ.: In search of a dose-response relationship with radiotherapy in the management of recurrent rectal carcinoma in the pelvis: A systematic review. Int J Radiat Oncol Biol Phys, 40: 437–446, 1998.
18.
OvergaardM., OvergaardJ., SellA.: Dose-response relationship for radiation therapy of recurrent, residual, and primarily inoperable rectal cancer. Radiother Oncol, 1: 217–225, 1984.
19.
RewD.A., WilsonG.D., TaylorI.: Proliferation characteristics of human colorectal carcinomas in vivo. Br J Surg, 78: 60–66, 1991.
20.
JanjanN.A., CraneC.N., FeigB.W.: Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys, 47: 713–718, 2000.
21.
Glynne-JonesR., SaundersM.I., HoskinP., PhillipsH.: A pilot study of continuous, hyperfractionated, accelerated radiotherapy in rectal adenocarcinoma. Clin Onol, 11: 334–339, 1999.
22.
CapirciC., PolicoC., MandolitiG., PavanatoG.: Dislocation of small bowel volume within box pelvic treatment fields, using the new Up Down Table device. Int J Radiat Oncol Biol Phys, 51: 465–473, 2001
23.
ICRU 1999.International Commission on Radiation Units and Measurements, Prescribing, Recording and Reporting Photon Beam Therapy (Supplement to ICRU Report 50). ICRU Report 62, Bethesda, Maryland, USA, 1999.
24.
CapirciC., CesareP., MandolitiG., PavanatoG., GavaM., SalviatoS.: The role of a conventional simulator in multileaf-plan simulation: a proposal. Tumori, 2: 91–95, 2001.
25.
CapirciC., PolicoC., MandolitiG.Control of small bowel motion and set-up errors during box pelvic treatment using the new “Up Down Table” device. Radiother Oncol, 40(suppl 1): S195, 1996.
26.
ValentiniV., GenovesiD., PolicoC., CapirciC.: Quality assurance procedures in radiotherapy of rectal neoplasm. Rays, 21: 649–662, 1996.
